Skip to content
VuFind
Advanced
  • HALF OF WOMEN WITH EARLY BREAS...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY
QR Code

HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY

Bibliographic Details
Main Authors: Kemp, A., Roughead, E., Saunders, C., Boyle, F., Bulsara, M., Malacova, Eva, Preen, D.
Format: Conference Paper
Published: 2014
Online Access:http://hdl.handle.net/20.500.11937/57739
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/57739

Similar Items

  • Early discontinuation of endocrine therapy for breast cancer: Who is at risk in clinical practice?
    by: Kemp, A., et al.
    Published: (2014)
  • Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice
    by: Kemp, A., et al.
    Published: (2014)
  • Endocrine therapy for breast cancer: a model of hormonal manipulation
    by: Johnston, Simon J., et al.
    Published: (2018)
  • Optimising endocrine therapy in postmenopausal women with advanced breast cancer
    by: Yau, Thomas Ho Lai, et al.
    Published: (2018)
  • Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer
    by: Alfarsi, Lutfi, et al.
    Published: (2018)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips